Equivocal Notions of Accuracy and Genetic Screening of the General Population

Mount Sinai Journal of Medicine

Volumn 65, Issue 3, 1998, Pages 178-184

  Smith, Kelly C ^a  

^a CLEMSON UNIVERSITY   (United States)

Author keywords

Abortion; BRCA1; Cystic fibrosis; Genetic determinism; Genetic screening; Genetic testing; Reproductive technology

Indexed keywords

ARTICLE; ATTITUDE TO HEALTH; CYSTIC FIBROSIS; FEMALE; GENETIC COUNSELING; GENETIC PROCEDURES; GENETIC SCREENING; GENETICS; GENETICS AND REPRODUCTION; HUMAN; POPULATION GENETICS; PRENATAL DIAGNOSIS; REPRODUCIBILITY; STANDARD;

GENETICS AND REPRODUCTION;

ATTITUDE TO HEALTH; CYSTIC FIBROSIS; FEMALE; GENETIC COUNSELING; GENETIC SCREENING; GENETIC TECHNIQUES; GENETICS, POPULATION; HUMANS; PREIMPLANTATION DIAGNOSIS; PRENATAL DIAGNOSIS; REPRODUCIBILITY OF RESULTS;

EID: 0346312961     PISSN: 00272507     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (24)

1. Gilbert W. The future of genetic testing. Paper given at the Boston University Colloquium in Philosophy of Science, October 2, 1996, Boston.
2. Committee on Assessing Genetic Risks (CAGR), Division of Health Science Policy, Institute of Medicine. Assessing genetic risks. Washington, DC: National Academy Press; 1994.
3. American College of Obstetricians and Gynecologists (ACOG). Professional liability implication of AFP testing (liability alert). Washington, DC: ACOG; 1985.
4. Press NA, Browner CH. Collective silences, collective fictions: how prenatal diagnostic testing became part of routine prenatal care. In: Rothenberg KH, Thomson EJ, editors. Women and prenatal testing. Columbus, OH: Ohio State University Press; 1994. p. 201-218.
5. Koch L, Stemerding D. The sociology of entrenchment: a cystic fibrosis test for everyone? Soc Sci Med 1994; 39: 1211-1220.
6. Wilfrond BS, Nolan K. National policy development for the clinical application of genetic diagnostic technologies. JAMA 1993; 270:2948-2954.
7. Wilfrond BS. Screening policy for cystic fibrosis: the role of evidence. Hastings Cent Rep 1995; 25:821-23.
8. Burian RN. Sociobiology and genetic determinism. Philos Forum 1981-82; 13:43-66.
9. Smith K. The new problem of genetics. Biol Philos 1992; 7:331-348.
10. Webster P, Vanacore L, Nairn AL, et al. Cellular localization of CFTR to endosomes in a ductal epithelium. J Am Physiol 1994; 267:C340-348.
11. Kerem E, Corey M, Kerem BS, et al. The relation between genotype and phenotype in cystic fibrosis: analysis of the most common mutation (delta F508). N Engl J Med 1990; 323:1517-1522.
12. Carswell F. Whole-population screening for carriers of cystic fibrosis gene. Lancet 1996; 347:1421-1422.
13. Faden R, Tambor ES, Chase GA, et al. Attitudes of physicians and genetics professionals towards cystic fibrosis carrier screening. Am J Med Genet 1994; 50:1-11.
14. Wulff HR. The causal basis of the current disease classification. In: Nordenfeldt L, Lindahl BIB, editors. Health, disease and causal explanations in medicine. Dordrecht, Netherlands: D. Reidel Publishing Co; 1984. p. 169-177.
15. The Cystic Fibrosis Genotype-Phenotype Consortium. Correlation between genotype and phenotype in patients with cystic fibrosis. N Engl J Med 1993; 329: 1308-1313.
16. Highsmith WE, Lauranell HB, Zhaoqing Z, et al. A novel mutation in the cystic fibrosis gene in patients with pulmonary disease but normal sweat chloride concentrations. N Engl J Med 1994; 331:974-980.
17. Cutting G, Carristin SM, Nash E. Analysis of four diverse population groups indicates that a subset of cystic fibrosis mutations occur in common among Caucasians. Am J Hum Genet 1992; 50:1185-1194.
18. Slocic P. Perception of risk. Science 1987; 236:280-285.
19. Axworthy D, Brock DJH, Bobrow M, Marteau TM. Psychological impact of population-based carrier testing for cystic fibrosis: 3 year follow-up. Lancet 1996; 347:1443-1446.
20. Giardiello FM, Brensinger JD, Petersen GM, et al. The use and interpretation of commercial APC gene testing for familial adenomatus polyposis. N Engl J Med 1997; 336:823-827.
21. Ost D. The 'right' not to know. J Med Philos 1984; 9:301-312.
22. Clayton EW. Anonymous genetic testing: reply to Mehlman et al. Am J Hum Genet 1996; 59:1169.
23. Rothenberg KH, Thomson EJ. Women and prenatal testing: an introduction to the issues. In: Rothenberg KH, Thomson EJ, editors. Women and prenatal testing: facing the challenges of genetic technology. Columbus, OH: Ohio State University Press; 1994. p. 1-4.
24. U.S. Congress, Office of Technology Assessment. Cystic fibrosis and DNA tests: implications of carrier screening. Washington, DC: U.S. Government Printing Office; 1992.